U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C17H19N3.C4H4O4
Molecular Weight 381.425
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of ESMIRTAZAPINE MALEATE

SMILES

OC(=O)\C=C/C(O)=O.[H][C@]12CN(C)CCN1C3=C(CC4=C2C=CC=C4)C=CC=N3

InChI

InChIKey=RPUBHMMISKEXSR-MLCLTIQSSA-N
InChI=1S/C17H19N3.C4H4O4/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20;5-3(6)1-2-4(7)8/h2-8,16H,9-12H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t16-;/m1./s1

HIDE SMILES / InChI
Esmirtazapine (S-(+)mirtazapine or ORG-50081) is an enantiomer of mirtazapine (REMERON®), a high-affinity antagonist at 5-HT2/5-HT3 and H1 receptors, used in the treatment of depression. Esmirtazapine has a shorter plasma half-life than the R(−) enantiomer. Esmirtazapine is preferentially metabolized into an 8-hydroxy glucuronide. Organon was developing esmirtazapine for the treatment of hot flushes (vasomotor symptoms) associated with the menopause and insomnia.

Approval Year

PubMed

PubMed

TitleDatePubMed
Pathophysiology of depression and mechanisms of treatment.
2002 Mar
Hypertensive urgency with clonidine and mirtazepine.
2004 Sep-Oct
The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants.
2005
Mirtazepine for MDMA-induced depression.
2005 May-Jun
Linezolid-associated serotonin syndrome after concomitant treatment with citalopram and mirtazepine in a critically ill bone marrow transplant recipient.
2005 Nov-Dec
Chiral resolution and binding study of 1,3,4,14b-tetrahydro-2,10-dimethyl-2H,10H-pyrazino[2,1-d]pyrrolo[1,2-b] [1,2,5]benzotriazepine (10-methyl-10-azaaptazepine) and 2-methyl-1,3,4,14b-tetrahydro-2H-pyrazino[2,1-d]pyrrolo[1,2-b] [1,2,5]benzothiadiazepine 10,10-dioxide (tiaaptazepine).
2005 Nov-Dec
[Distribution effects of orthographic similarity and priming by masked repetition].
2005 Sep
[Compliance in psychiatry: results of a survey of depressed patients using orally disintegrating tablet].
2006
Family history, early adversity and the hypothalamic-pituitary-adrenal (HPA) axis: Mediation of the vulnerability to mood disorders.
2007
[Differentiated approach to the therapy of endogenous anxious depression].
2007
[Depressive disturbances during antiviral therapy in patients with type C hepatitis].
2007
Post-traumatic stress disorder.
2007 Aug 1
A new paradigm for the prediction of antidepressant treatment response.
2009
Brain-derived neurotrophic factor: role in depression and suicide.
2009
Early presentation following overdose of modified-release paracetamol (Panadol Osteo) with biphasic and prolonged paracetamol absorption.
2009 Aug 7
Undertreatment of menopausal symptoms and novel options for comprehensive management.
2009 Nov
Extreme thermal sensitivity and pain-induced sensitization in a fibromyalgia patient.
2010
3D-QSAR design of new escitalopram derivatives for the treatment of major depressive disorders.
2010 Apr-Jun
Behavioral and developmental changes in rats with prenatal exposure of mirtazapine.
2010 Jul-Sep
Patents

Sample Use Guides

Phase III trials: 0.5-18 mg once daily for 1-52 weeks
Route of Administration: Oral
Name Type Language
ESMIRTAZAPINE MALEATE
USAN   WHO-DD  
USAN  
Official Name English
Esmirtazapine maleate [WHO-DD]
Common Name English
(+)-(14BS)-2-METHYL-1,2,3,4,10,14B-HEXAHYDROPYRAZINO(2,1-A)PYRIDO(2,3-C)(2)BENZAZEPINE (2Z)-BUTENEDIOATE
Common Name English
ORG-50081
Code English
PYRAZINO(2,1-A)PYRIDO(2,3-C)(2)BENZAZEPINE, 1,2,3,4,10,14B-HEXAHYDRO-2-METHYL-, (14BS)-, (2Z)-2-BUTENEDIOATE (1:1)
Common Name English
ORG 50081
Code English
MIRTAZAPINE MALEATE, (S)-
Common Name English
ESMIRTAZAPINE MALEATE [USAN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29756
Created by admin on Fri Dec 15 15:45:52 GMT 2023 , Edited by admin on Fri Dec 15 15:45:52 GMT 2023
Code System Code Type Description
DRUG BANK
DBSALT001294
Created by admin on Fri Dec 15 15:45:52 GMT 2023 , Edited by admin on Fri Dec 15 15:45:52 GMT 2023
PRIMARY
PUBCHEM
6451144
Created by admin on Fri Dec 15 15:45:52 GMT 2023 , Edited by admin on Fri Dec 15 15:45:52 GMT 2023
PRIMARY
ChEMBL
CHEMBL1366933
Created by admin on Fri Dec 15 15:45:52 GMT 2023 , Edited by admin on Fri Dec 15 15:45:52 GMT 2023
PRIMARY
USAN
RR-49
Created by admin on Fri Dec 15 15:45:52 GMT 2023 , Edited by admin on Fri Dec 15 15:45:52 GMT 2023
PRIMARY
CAS
680993-85-5
Created by admin on Fri Dec 15 15:45:52 GMT 2023 , Edited by admin on Fri Dec 15 15:45:52 GMT 2023
PRIMARY
NCI_THESAURUS
C76940
Created by admin on Fri Dec 15 15:45:52 GMT 2023 , Edited by admin on Fri Dec 15 15:45:52 GMT 2023
PRIMARY
SMS_ID
100000174954
Created by admin on Fri Dec 15 15:45:52 GMT 2023 , Edited by admin on Fri Dec 15 15:45:52 GMT 2023
PRIMARY
FDA UNII
I2U18E6JKA
Created by admin on Fri Dec 15 15:45:52 GMT 2023 , Edited by admin on Fri Dec 15 15:45:52 GMT 2023
PRIMARY